_id
690f39c8ccc777a4e85d18fd
Ticker
BVAXF
Name
Biovaxys Technology Corp
Exchange
OTCQB
Address
146 Thirtieth Street, Etobicoke, ON, Canada, M8W 3D4
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://biovaxys.com
Description
BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics. The company offers DPX immune educating technology platform and HapTenix neoantigen tumor cell construct platform for treating cancers, infectious diseases, antigen desensitization, and other immune diseases. It also provides Maveropepimut-S (MVP-S), which has completed phase IIb clinical trial for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma and for platinum resistant ovarian cancer; MVP-S +1 Keytruda that is in IIb clinical trial to treat lung cancer, bladder cancer, liver cancer, DLBCL, and ovarian cancer subpopulations; BVX-0918, a haptenized tumor cell vaccine for ovarian cancer; and DPX SurMAGE, a formulation of the tumor-associated antigens survivin and MAGE A9 as a dual targeted immunotherapy. In addition, the company develops DPX-RSV that is in phase II clinical stage for Respiratory Syncytial Virus; DPX-Flu, which is in phase I clinical stage used to treat multiple strains of influenza; DPX-Neo, which is in phase I trial used for evaluating UConn Health's proprietary neoepitopes; DPX-E7 to evaluate changes in CD8+ T cells in peripheral blood and tumor tissue and evaluate the safety in HLA-A2positive patients; and DPX-rPA anthrax vaccine. Further, the company operates HapTenix Platform, a vaccine platform based on the established immunological concept that modifies surface proteins with haptens and T-Cell Antigen Discovery Program. It has agreement with AP Visionaries, Inc. to develop a proprietary DPX formulation to address the urgent need for a therapy to treat or alleviate the potentially life-threatening risk of certain food allergies triggered by exposure to peanut/tree nuts or eggs. BioVaxys Technology Corp. is headquartered in Etobicoke, Canada.
Last Close
0.1625
Volume
38856
Current Price
0.173
Change
0.002
Last Updated
2026-01-01T02:50:00.292Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
7581722
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-04-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1290159
Operating Income
-1290159
Interest Expense
-
Pretax Income
-1316689
Net Income
-1316689
Eps
-0.045165529429359794
Dividends Per Share
-
Shares Outstanding
40654172
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-26530
Cash
4309
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
1100321
Property Plant Equipment
-
Total Assets
1100321
Payables
1524349
Short Term Debt
-
Long Term Debt
-
Total Liabilities
3831367
Equity
-2731046
Bs_currency_symbol
CAD
Depreciation
-
Change In Working Capital
971401
Cash From Operations
-8166
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
903538
Net Change In Cash
-153110
Cf_currency_symbol
CAD
PE
-
PB
-1.8466865662460463
ROE
48.21189390438681
ROA
-119.66407984579047
FCF
-8166
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
1
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-04-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1290159
Quarters > 0 > income Statement > operating Income
-1290159
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1316689
Quarters > 0 > income Statement > net Income
-1316689
Quarters > 0 > income Statement > eps
-0.045165529429359794
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
29152520
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-26530
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
4309
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1100321
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
1100321
Quarters > 0 > balance Sheet > payables
1524349
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3831367
Quarters > 0 > balance Sheet > equity
-2731046
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-1316689
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
971401
Quarters > 0 > cash Flow > cash From Operations
-8166
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
903538
Quarters > 0 > cash Flow > net Change In Cash
-153110
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.045165529429359794
Quarters > 0 > ratios > PB
-1.8466865662460463
Quarters > 0 > ratios > ROE
48.21189390438681
Quarters > 0 > ratios > ROA
-119.66407984579047
Quarters > 0 > ratios > FCF
-8166
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-01-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1205557
Quarters > 1 > income Statement > operating Income
-1205557
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1070198
Quarters > 1 > income Statement > net Income
-1070198
Quarters > 1 > income Statement > eps
-0.03750184802598236
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
28537207
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
135359
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
157415
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1281310
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
1281310
Quarters > 1 > balance Sheet > payables
1499444
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3024088
Quarters > 1 > balance Sheet > equity
-1742778
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-1070198
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
285308
Quarters > 1 > cash Flow > cash From Operations
-892645
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
847073
Quarters > 1 > cash Flow > net Change In Cash
-54387
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.03750184802598236
Quarters > 1 > ratios > PB
-2.8327972989101307
Quarters > 1 > ratios > ROE
61.407591787364765
Quarters > 1 > ratios > ROA
-83.52373742497913
Quarters > 1 > ratios > FCF
-892645
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-10-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1499245
Quarters > 2 > income Statement > operating Income
-1499245
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2743983
Quarters > 2 > income Statement > net Income
-2743983
Quarters > 2 > income Statement > eps
-0.10470879993241204
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
26205849
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-1244738
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
211806
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1300764
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1300764
Quarters > 2 > balance Sheet > payables
1556860
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3220886
Quarters > 2 > balance Sheet > equity
-1920122
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-2743983
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
135649
Quarters > 2 > cash Flow > cash From Operations
-1015489
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
733074
Quarters > 2 > cash Flow > net Change In Cash
-279039
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.10470879993241204
Quarters > 2 > ratios > PB
-2.361106157317087
Quarters > 2 > ratios > ROE
142.9067007200584
Quarters > 2 > ratios > ROA
-210.95164072806446
Quarters > 2 > ratios > FCF
-1015489
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-07-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
886378
Quarters > 3 > income Statement > operating Income
-886378
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1186461
Quarters > 3 > income Statement > net Income
-1186461
Quarters > 3 > income Statement > eps
-0.04904481413099261
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
24191365
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-300083
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
490845
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1024030
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
2407649
Quarters > 3 > balance Sheet > payables
1510654
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2656844
Quarters > 3 > balance Sheet > equity
-249195
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-1186461
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-518494
Quarters > 3 > cash Flow > cash From Operations
-412198
Quarters > 3 > cash Flow > capital Expenditures
1
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
743398
Quarters > 3 > cash Flow > net Change In Cash
331105
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.04904481413099261
Quarters > 3 > ratios > PB
-16.794502879271253
Quarters > 3 > ratios > ROE
476.11749834466985
Quarters > 3 > ratios > ROA
-49.278819296334305
Quarters > 3 > ratios > FCF
-412199
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-10-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
3295516
Annuals > 0 > income Statement > operating Income
-3295516
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-3954781
Annuals > 0 > income Statement > net Income
-3954781
Annuals > 0 > income Statement > eps
-0.15091214942129905
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
26205849
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-659265
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
211806
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1300764
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
1300764
Annuals > 0 > balance Sheet > payables
1556860
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3220886
Annuals > 0 > balance Sheet > equity
-1920122
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-3954781
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
53942
Annuals > 0 > cash Flow > cash From Operations
-1862237
Annuals > 0 > cash Flow > capital Expenditures
1056364
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3127083
Annuals > 0 > cash Flow > net Change In Cash
210829
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.15091214942129905
Annuals > 0 > ratios > PB
-2.3106085111779358
Annuals > 0 > ratios > ROE
205.9650897182575
Annuals > 0 > ratios > ROA
-304.03524390281405
Annuals > 0 > ratios > FCF
-2918601
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-10-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
6453188
Annuals > 1 > income Statement > operating Income
-6453188
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-7687317
Annuals > 1 > income Statement > net Income
-7687317
Annuals > 1 > income Statement > eps
-0.529751263542832
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
14511182
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1258977
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
977
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
113478
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
113478
Annuals > 1 > balance Sheet > payables
2655875
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3485539
Annuals > 1 > balance Sheet > equity
-3372061
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-7687317
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
2189039
Annuals > 1 > cash Flow > cash From Operations
-1054849
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
917100
Annuals > 1 > cash Flow > net Change In Cash
-140921
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.529751263542832
Annuals > 1 > ratios > PB
-0.7285583245973308
Annuals > 1 > ratios > ROE
227.97087597169804
Annuals > 1 > ratios > ROA
-6774.279596045048
Annuals > 1 > ratios > FCF
-1054849
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-10-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
4081793
Annuals > 2 > income Statement > operating Income
-4081793
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-11727444
Annuals > 2 > income Statement > net Income
-11727444
Annuals > 2 > income Statement > eps
-0.11944864300549968
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
98179801
Annuals > 2 > income Statement > income Tax Expense
7641848
Annuals > 2 > income Statement > EBITDA
3579629
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-7661422
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
141898
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
212001
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
714529
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
865564
Annuals > 2 > balance Sheet > payables
1312736
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1639096
Annuals > 2 > balance Sheet > equity
-773532
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11727444
Annuals > 2 > cash Flow > depreciation
3802.8
Annuals > 2 > cash Flow > change In Working Capital
1925476
Annuals > 2 > cash Flow > cash From Operations
-1574609
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1108245
Annuals > 2 > cash Flow > net Change In Cash
-451217
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.11944864300549968
Annuals > 2 > ratios > PB
-21.48823876620489
Annuals > 2 > ratios > ROE
1516.0903492033945
Annuals > 2 > ratios > ROA
-1354.8904529301126
Annuals > 2 > ratios > FCF
-1574609
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-10-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
6442033
Annuals > 3 > income Statement > operating Income
-6442033
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-6457939
Annuals > 3 > income Statement > net Income
-6457939
Annuals > 3 > income Statement > eps
-0.07787211953186621
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
82930053
Annuals > 3 > income Statement > income Tax Expense
9926.75
Annuals > 3 > income Statement > EBITDA
-6418471
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-23562
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
593115
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
132906
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
874487
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
8503584
Annuals > 3 > balance Sheet > payables
216465
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
326863
Annuals > 3 > balance Sheet > equity
8176721
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6457939
Annuals > 3 > cash Flow > depreciation
5979.26
Annuals > 3 > cash Flow > change In Working Capital
-83352
Annuals > 3 > cash Flow > cash From Operations
-5294426
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
3438986
Annuals > 3 > cash Flow > net Change In Cash
-1829980
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.07787211953186621
Annuals > 3 > ratios > PB
1.7170768053477672
Annuals > 3 > ratios > ROE
-78.9795689494603
Annuals > 3 > ratios > ROA
-75.94373149015756
Annuals > 3 > ratios > FCF
-5294426
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.045165529429359794
Valuation > metrics > PB
-1.8466865662460463
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
48.21189390438681
Profitability > metrics > ROA
-119.66407984579047
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-48.63019223520543
Risk > final Score
-165
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.7218301058353435
Liquidity > metrics > Quick Ratio
0.7218301058353435
Liquidity > final Score
46
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-6
Prev Risks > 1
25
Prev Risks > 2
18
Prev Liquidities > 0
53
Prev Liquidities > 1
52
Prev Liquidities > 2
44
Updated At
2026-01-20T21:32:28.068Z
Earnings History > 0 > period
2025-07-31
Earnings History > 0 > report Date
2025-10-02
Earnings History > 0 > date
2025-07-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.03
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.03
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-04-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-04-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.05
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-01-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-01-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0029
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-10-31
Earnings History > 3 > report Date
2024-10-31
Earnings History > 3 > date
2024-10-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0077
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-07-31
Earnings History > 4 > report Date
2024-07-31
Earnings History > 4 > date
2024-07-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0039
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-04-30
Earnings History > 5 > report Date
2024-04-30
Earnings History > 5 > date
2024-04-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0019
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-01-31
Earnings History > 6 > report Date
2024-01-31
Earnings History > 6 > date
2024-01-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
0.0026
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-10-31
Earnings History > 7 > report Date
2023-10-31
Earnings History > 7 > date
2023-10-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0186
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-07-31
Earnings History > 8 > report Date
2023-07-31
Earnings History > 8 > date
2023-07-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.008
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-04-30
Earnings History > 9 > report Date
2023-04-30
Earnings History > 9 > date
2023-04-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0084
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-01-31
Earnings History > 10 > report Date
2023-01-31
Earnings History > 10 > date
2023-01-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.0062
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-10-31
Earnings History > 11 > report Date
2022-10-31
Earnings History > 11 > date
2022-10-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.059
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-07-31
Earnings History > 12 > report Date
2022-07-31
Earnings History > 12 > date
2022-07-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.0072
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-04-30
Earnings History > 13 > report Date
2022-04-30
Earnings History > 13 > date
2022-04-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.0086
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-01-31
Earnings History > 14 > report Date
2022-01-31
Earnings History > 14 > date
2022-01-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.0104
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-10-31
Earnings History > 15 > report Date
2021-10-31
Earnings History > 15 > date
2021-10-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.0217
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-07-31
Earnings History > 16 > report Date
2021-07-31
Earnings History > 16 > date
2021-07-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CAD
Earnings History > 16 > eps Actual
-0.0089
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-04-30
Earnings History > 17 > report Date
2021-07-31
Earnings History > 17 > date
2021-04-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CAD
Earnings History > 17 > eps Actual
-0.0088
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-01-31
Earnings History > 18 > report Date
2021-04-30
Earnings History > 18 > date
2021-01-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CAD
Earnings History > 18 > eps Actual
-0.015
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.015
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-10-31
Earnings History > 19 > report Date
2021-01-31
Earnings History > 19 > date
2020-10-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CAD
Earnings History > 19 > eps Actual
-0.0157
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0157
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-07-31
Earnings History > 20 > report Date
2020-07-31
Earnings History > 20 > date
2020-07-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
CAD
Earnings History > 20 > eps Actual
-0.0078
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-04-30
Earnings History > 21 > report Date
2020-07-31
Earnings History > 21 > date
2020-04-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CAD
Earnings History > 21 > eps Actual
-0.0059
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-01-31
Earnings History > 22 > report Date
2020-04-30
Earnings History > 22 > date
2020-01-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
CAD
Earnings History > 22 > eps Actual
-0.0021
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0021
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-10-31
Earnings History > 23 > report Date
2020-01-31
Earnings History > 23 > date
2019-10-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CAD
Earnings History > 23 > eps Actual
-0.0011
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0011
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-07-31
Earnings History > 24 > report Date
2019-07-31
Earnings History > 24 > date
2019-07-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CAD
Earnings History > 24 > eps Actual
-0.0013
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-04-30
Earnings History > 25 > report Date
2019-04-30
Earnings History > 25 > date
2019-04-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CAD
Earnings History > 25 > eps Actual
-0.0021
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-01-31
Earnings History > 26 > report Date
2019-01-31
Earnings History > 26 > date
2019-01-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CAD
Earnings History > 26 > eps Actual
-0.0026
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics. The company offers DPX immune educating technology platform and HapTenix neoantigen tumor cell construct platform for treating cancers, infectious diseases, antigen desensitization, and other immune diseases. It also provides Maveropepimut-S (MVP-S), which has completed phase IIb clinical trial for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma and for platinum resistant ovarian cancer; MVP-S +1 Keytruda that is in IIb clinical trial to treat lung cancer, bladder cancer, liver cancer, DLBCL, and ovarian cancer subpopulations; BVX-0918, a haptenized tumor cell vaccine for ovarian cancer; and DPX SurMAGE, a formulation of the tumor-associated antigens survivin and MAGE A9 as a dual targeted immunotherapy. In addition, the company develops DPX-RSV that is in phase II clinical stage for Respiratory Syncytial Virus; DPX-Flu, which is in phase I clinical stage used to treat multiple strains of influenza; DPX-Neo, which is in phase I trial used for evaluating UConn Health's proprietary neoepitopes; DPX-E7 to evaluate changes in CD8+ T cells in peripheral blood and tumor tissue and evaluate the safety in HLA-A2positive patients; and DPX-rPA anthrax vaccine. Further, the company operates HapTenix Platform, a vaccine platform based on the established immunological concept that modifies surface proteins with haptens and T-Cell Antigen Discovery Program. It has agreement with AP Visionaries, Inc. to develop a proprietary DPX formulation to address the urgent need for a therapy to treat or alleviate the potentially life-threatening risk of certain food allergies triggered by exposure to peanut/tree nuts or eggs. BioVaxys Technology Corp. is headquartered in Etobicoke, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS PR Newswire
Read more →Showing 2 of 6
(Last Updated 2025-04-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Biovaxys Technology Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-07-31
EPS Actual
-0.03
EPS Estimate
0
EPS Difference
-0.03
Surprise Percent
0%
(Last Updated 2025-04-30)
(Last Updated 2025-04-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-04-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-04-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.